Source: Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marjan Kerkhof, Elizabeth V. Hillyer, David B. Price. The effect of smoking on exacerbation risk in eosinophilic patients with COPD. Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017

Member's Comments

No comment yet.

Related content which might interest you: Lack of effect of acute exacerbations on disease progression in ex-smoker COPD patients Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function Year: 2010 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The influence of smoking on hydrolipoperoxidation in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 306s Year: 2003 Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Smoking and concomitant medication as risk factors for exacerbation of bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 45s Year: 2005 The tobacco smoking influence on parodontic inflammation in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 167s Year: 2007 The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Tobacco smoking habits by patients with chronic obstructive pulmonary disease (COPD) and their impact on number of hospitalizations Source: Eur Respir J 2007; 30: Suppl. 51, 169s Year: 2007 The impact of smoking cessation on respiratory symptoms in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 391s Year: 2005 The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 The impact of airway infection on cardiovascular risk during COPD exacerbations Source: Annual Congress 2012 - Acute exacerbation in COPD Year: 2012 Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status Source: Eur Respir J 2002; 20: Suppl. 38, 620s Year: 2002 COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005